Global Animal Antimicrobials and Antibiotics Market, By Product Type (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone, Aminoglycosides, and Lincosamides), Mode of Delivery (Premixes, Oral Powder, Oral solutions, Premixes, and Injection), Animal (Food-Producing Animals and Companion Animals) – Industry Trends and Forecast to 2031.
Animal Antimicrobials and Antibiotics Market Analysis and Size
Animal antimicrobials and antibiotics market continues to evolve with a focus on reducing resistance and enhancing efficacy. Advancements include novel formulations and delivery systems, emphasizing safety and regulatory compliance. Technologies such as precision breeding and genomic tools are transforming treatment strategies. Growth is driven by rising livestock production and stringent health standards. Continuous innovation ensures sustainable practices amid global health concerns.
The global animal antimicrobials and antibiotics market size was valued at USD 2.56 billion in 2023 and is projected to reach USD 3.64 billion by 2031, with a CAGR of 4.50% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016 - 2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone, Aminoglycosides, and Lincosamides), Mode of Delivery (Premixes, Oral Powder, Oral solutions, Premixes, and Injection), Animal (Food-Producing Animals and Companion Animals)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Zoetis Services LLC (U.S.), Boehringer Ingelheim International GmbH (Germany), Merck & Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Bayer AG (Germany), Dechra Pharmaceuticals Limited (U.K.), Virbac (France), Vetoquinol (France), Sanofi (France), Elanco (U.S.), Endovac Animal Health (U.S.), ECO - Animal Health Ltd. (U.K.), Indian Immunologicals Ltd. (India), Ashish Life Science (India), and Lutim Pharma Private Limited (India)
|
|
Market Opportunities
|
|
Market Definition
Animal antimicrobials and antibiotics refer to medications used in veterinary medicine to treat and prevent bacterial infections in animals. These drugs are crucial for maintaining animal health and welfare in agriculture, companion animals, and wildlife conservation. However, their use requires careful management to prevent antibiotic resistance and ensure food safety. Regulatory frameworks govern their use to promote responsible antibiotic stewardship in animal populations.
Animal Antimicrobials and Antibiotics Market Dynamics
Drivers
- Increasing Demand for Animal Protein
The increasing global demand for animal protein, driven by population growth and dietary shifts towards higher protein intake, fuels the need for antibiotics in livestock. These medications are crucial for preventing and treating diseases, ensuring uninterrupted production of meat, milk, and eggs. For instance, in intensive poultry farming, antibiotics are essential to control infections such as avian influenza, maintaining the health and productivity of large-scale poultry operations worldwide.
- Rising Incidences of Animal Diseases
The rising incidence of infectious diseases in livestock poses significant threats to health and productivity, driving the demand for antibiotics. For example, outbreaks of avian influenza and foot-and-mouth disease necessitate immediate intervention to prevent widespread economic losses in poultry and livestock sectors. Antibiotics play a crucial role in controlling these outbreaks, ensuring animal welfare and sustaining agricultural productivity, thereby driving growth in the animal antimicrobials and antibiotics market.
Opportunities
- Technological Advancements in Veterinary Medicine
Technological advancements in veterinary medicine, such as advanced diagnostic tools and precision treatments, are creating opportunities in the antibiotics and antimicrobials market. For instance, the development of rapid diagnostic tests enables early detection of diseases, facilitating targeted antibiotic use. Additionally, innovations in vaccine development offer preventative solutions, reducing the reliance on antibiotics. These advancements not only improve animal health outcomes but also drive demand for more effective and specialized antimicrobial products.
- Increased Investments in Animal Healthcare
Increased investments in animal healthcare, particularly by pharmaceutical companies and agricultural stakeholders, present significant opportunities in the antibiotics market. These investments fuel research and development efforts aimed at developing new formulations and therapies that enhance animal health outcomes. For instance, collaborations between veterinary experts and pharmaceutical firms have led to innovative antibiotics that effectively combat emerging diseases in livestock, thereby expanding the market's product offerings and capabilities.
Restraints/Challenges
- Concern of Antibiotic Resistance
Increased use of antibiotics in animal agriculture fuels antibiotic-resistant bacteria, posing severe risks through foodborne transmission and undermining antibiotic efficacy in veterinary and human medicine. This threat amplifies public health concerns, limiting treatment options and complicating disease management. Regulatory pressures and consumer awareness drive stringent measures, challenging traditional farming practices reliant on antibiotics. Addressing these issues demands substantial changes in agricultural practices and heightened vigilance in antibiotic stewardship.
- Complex Supply Chain and Distribution Issues
The complex supply chain and distribution issues in the animal antimicrobials market pose significant challenges. Varied regulatory demands across regions complicate logistics, potentially delaying access to essential products. This logistical complexity and regulatory disparity hinder market efficiency, exacerbating difficulties in ensuring proper distribution and administration of antimicrobials across diverse farming operations.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
Recent Developments
- In July 2020, Trianni Inc. (USA) and Zoetis (USA) initiated a collaboration aimed at developing transgenic monoclonal antibody platforms to innovate veterinary medications. This partnership seeks to leverage Trianni's expertise in antibody discovery and Zoetis's leadership in animal health solutions. The FDA recently approved Zoetis's acquisition of Marboquin (USA), marking a strategic move to bolster their portfolio and capabilities in the veterinary pharmaceutical sector.
Animal Antimicrobials and Antibiotics Market Scope
The market is segmented on the basis of product type, mode of delivery and animal. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Tetracycline
- Penicillin
- Sulfonamide
- Macrolide
- Cephalosporin
- Fluoroquinolone
- Aminoglycosides
- Lincosamides
Mode of Delivery
- Premixes
- Oral Powder
- Oral solutions
- Premixes
- Injection
Animal
- Food-Producing Animals
- Cattle
- Pigs
- Poultry
- Sheep and Goats
- Other
- Companion Animals
- Dogs
- Cats
- Horses
- Other
Animal Antimicrobials and Antibiotics Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, product type, mode of delivery and animal as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the animal antimicrobials and antibiotics market due to its burgeoning animal population, expanding pet insurance sector, increasing demand for animal-derived foods, and rising expenditures on animal health. These factors collectively drive growth in the region's veterinary pharmaceuticals market.
Asia-Pacific is expected to witness the highest CAGR in the animal antimicrobials and antibiotics market due to the region's growing animal population and rising demand for animal-derived food products. This trend reflects increasing awareness and adoption of veterinary healthcare practices to ensure animal health and productivity across diverse economies in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Animal Antimicrobials and Antibiotics Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Zoetis Services LLC (U.S.)
- Boehringer Ingelheim International GmbH (Germany)
- Merck & Co., Inc. (U.S.)
- Eli Lilly and Company (U.S.)
- Bayer AG (Germany)
- Dechra Pharmaceuticals Limited (U.K.)
- Virbac (France)
- Vetoquinol (France)
- Sanofi (France)
- Elanco (U.S.)
- Endovac Animal Health (U.S.)
- ECO - Animal Health Ltd. (U.K.)
- Indian Immunologicals Ltd. (India)
- Ashish Life Science (India)
- Lutim Pharma Private Limited (India)
SKU-